期刊文献+

消风散内服外洗联合NB-UVB治疗风热蕴肤型玫瑰糠疹的疗效观察

Therapeutic Effect Observation on Xiaofeng Powder Plus NB-UVB for Pityriasis Rosea of Wind -heat Accumulating Skin Type
下载PDF
导出
摘要 目的观察消风散内服外洗联合NB-UVB治疗风热蕴肤型玫瑰糠疹的临床疗效。方法将风热蕴肤型玫瑰糠疹患者156例随机分为2组。治疗组78例,用消风散内服外洗,NB-UVB照射治疗;对照组78例,口服抗组胺药、维生素C,外用炉甘石洗剂。疗程3周。观察两组治疗前后皮损变化及不良反应情况。根据ITT原则采用FAS进行分析。结果治疗组总有效率为89.7%,对照组为75.6%。两组比较,差异有显著性意义(P<0.05)。结论消风散内服外洗联合NB-UVB治疗风热蕴肤型玫瑰糠疹的临床疗效较好。 Objective To observe the clinical effect of pityriasis rosen of wind-heat accumulating skin type by Xiaofeng Powder taken orally and used externally plus narrow band UVB radiation. Method 156 cases of pityriasis rosea patients of wind-heat accumulating skin type were randomly divided into two groups. 78 eases in treatment group were treated by Xiaofeng Powder taken orally and used externally, radiatied with narrow band UVB; 78 cases in control group were treated by antihistamines and vitamin C taken orally, calamine lotion washout. Curative effects and side effects were evaluated in both groups after a 3-week course of treatment. According to the intention to treat analysis (ITT) principle, full analysis set (FAS) was anatysised. Result The total effective rate was 89.7% in treatment group and 75.6% in control group. There is significant difference between the two groups (P〈0.05) . Conclusion The clinical effect of pityriasis rosea of wind-heat accumulating skin type by Xiaofeng Powder taken orally and used externally plus narrow band UVB radiation is better.
出处 《中国医药指南》 2012年第19期60-61,共2页 Guide of China Medicine
关键词 玫瑰糠疹 中医药疗法 窄谱中波紫外线 Pityriasis Rosea TCM Therapy Narrow band UVB
  • 相关文献

参考文献1

二级参考文献27

  • 1Bianca S, Ingegnosi C, Ciancio B, et al. Pityriasis rosea in pregnancy. Reprod Toxicol, 2007, 24(3-4): 277-278.
  • 2Kyfiakis KP, Palamaras I, Terzoudi S, et al. Epidemiologic characteristics of pityriasis rosea in Athens Greece. Dermatol Online J, 2006, 12(1): 24.
  • 3Broccolo F, Drago F, Careddu AM, et al. Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. J Invest Dermatol, 2005, 124 (6): 1234- 1240.
  • 4Drago F, Broccolo F, Zaccaria E, et al. Pregnancy outcome in patients with pityriasis rosea. J Am Acad Dermatol, 2008, 58 (5 Suppl 1 ): S78-83.
  • 5Canpolat Kirac B, Adisen E, Bozdayi G, et al. The role of human herpesvirus 6, human herpesvirus 7, Epstein-Barr virus and cytomegalovirus in the aetiology of pityriasis rosea. J Eur Acad Dermatol Venereol, 2009, 23 ( 1 ): 16-21.
  • 6Prantsidis A, Rigopoulos D, Papatheodorou G, et al. Detection of human herpesvirus 8 in the skin of patients with pityriasis rosea.Acta Derm Venereol, 2009, 89(6): 604-606.
  • 7Mubki TF, Bin Dayel SA, Kadry R. A case of Pityriasis rosea concmTent with the novel influenza A (H1N1) infection. Pediatr Dermatol, 2011, 28(3): 341-342.
  • 8Kwon N, Kim J, Cho B, et al. A novel influenza a (H1N1) virus as a possible cause of pityriasis rosea? J Eur Acad Dermatol Venereol, 2011, 25 (3): 368-369.
  • 9Drago F, Broccolo F, Rebora A. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J Am Acad Dermatol, 2009, 61 (2): 303-318.
  • 10Brazzelli V, Prestinari F, Roveda E, et al. Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases. J Am Acad Dermatol, 2005, 53 (5 Suppl 1 ): $240-243.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部